SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-23-022060
Filing Date
2023-05-01
Accepted
2023-05-01 16:17:41
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-05-01

Document Format Files

Seq Description Document Type Size
1 ARS ny20007641x3_ars.pdf ARS 1266099
  Complete submission text file 0001140361-23-022060.txt   1742296
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38981 | Film No.: 23873926
SIC: 2834 Pharmaceutical Preparations